Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.58B |
| 2 |
Amphenol
APH
|
+$1.06B |
| 3 |
Eli Lilly
LLY
|
+$896M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$780M |
| 5 |
Snowflake
SNOW
|
+$615M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.24B |
| 2 |
NVIDIA
NVDA
|
+$1.89B |
| 3 |
Mercado Libre
MELI
|
+$1.5B |
| 4 |
Netflix
NFLX
|
+$1.32B |
| 5 |
Nike
NKE
|
+$826M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.63% |
| 2 | Communication Services | 15.64% |
| 3 | Consumer Discretionary | 12.05% |
| 4 | Healthcare | 9.65% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
TPG
TPG
$7.86B
| $13.6M | 0.01% |
+213,506
| New | +$12.6M |
|
377
Freshpet
FRPT
$3.22B
| $13.2M | 0.01% |
216,620
+2,057
| +1% | +$117K |
|
378
Prestige Consumer Healthcare
PBH
$2.6B
| $12.9M | 0.01% |
209,677
-42,539
| -17% | -$2.6M |
|
379
Ivanhoe Electric
IE
$1.74B
| $12.6M | 0.01% |
787,017
+450
| +0.1% | +$6.44K |
|
380
Hess Midstream
HESM
$5.11B
| $12.1M | 0.01% |
351,650
-90,079
| -20% | -$3.03M |
|
|
TTAN
381
ServiceTitan Inc
TTAN
$8.19B
| $12.1M | 0.01% |
113,466
-921
| -0.8% | -$90K |
|
382
CG Oncology
CGON
$6.66B
| $11.7M | 0.01% |
+282,506
| New | +$11.7M |
|
383
Corteva
CTVA
$51.3B
| $11.6M | 0.01% |
172,501
-108,848
| -39% | -$7.04M |
|
|
PCG.PRX
384
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.38B
| $11.4M | 0.01% |
279,165
| – | – |
|
385
Apollo Global Management
APO
$73.4B
| $11.1M | 0.01% |
76,829
-54,193
| -41% | -$7.2M |
|
386
CoStar Group
CSGP
$12.3B
| $11.1M | 0.01% |
164,960
+47,665
| +41% | +$3.38M |
|
387
Neurogene
NGNE
$712M
| $11M | 0.01% |
533,088
+138,999
| +35% | +$3.46M |
|
388
GFL Environmental
GFL
$14.9B
| $10.4M | 0.01% |
243,220
-467,357
| -66% | -$20.9M |
|
389
American Tower
AMT
$80.4B
| $10.2M | 0.01% |
57,955
-22,487
| -28% | -$4.09M |
|
390
Concrete Pumping Holdings
BBCP
$491M
| $10M | 0.01% |
1,495,209
-30,603
| -2% | -$201K |
|
391
Ormat Technologies
ORA
$6.65B
| $10M | 0.01% |
90,753
+30,910
| +52% | +$3.38M |
|
392
Diamondback Energy
FANG
$52.7B
| $9.91M | 0.01% |
65,937
-519
| -0.8% | -$76.6K |
|
393
Travere Therapeutics
TVTX
$5.78B
| $9.79M | 0.01% |
256,335
-828,015
| -76% | -$26.9M |
|
394
Kinetik
KNTK
$7.98B
| $9.74M | 0.01% |
270,126
+66,992
| +33% | +$2.42M |
|
395
Essent Group
ESNT
$6.33B
| $9.66M | 0.01% |
148,655
-229,969
| -61% | -$14.3M |
|
396
First Advantage
FA
$4.12B
| $9.21M | 0.01% |
633,878
-12,208
| -2% | -$172K |
|
397
Allient
ALNT
$1.92B
| $8.98M | 0.01% |
+167,114
| New | +$8.74M |
|
|
GDEN
398
DELISTED
Golden Entertainment
GDEN
| $8.78M | 0.01% |
322,886
-5,975
| -2% | -$155K |
|
399
Sanofi
SNY
$104B
| $8.65M | 0.01% |
178,539
-10,146
| -5% | -$503K |
|
400
Avalo Therapeutics
AVTX
$983M
| $8.64M | 0.01% |
+475,625
| New | +$8.03M |
|
Similar funds
Jennison Associates's Q4 2025 Portfolio in Review
As of Q4 2025, Jennison Associates held 652 positions worth $167B, down 3% from $172B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates withdrew a net $7.12B in Q4 2025, closing 78 positions and reducing 263 holdings. Its most notable exit was Nike, an estimated $826M position sold in full.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 41% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Merck worth $585M.
- Jennison Associates's largest Q4 2025 buy was Merck: 5,559,488 shares worth $585M.
- Jennison Associates added most to Advanced Micro Devices in Q4 2025, an estimated $1.58B increase.
- Jennison Associates's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $2.24B.
- Jennison Associates fully exited Nike in Q4 2025, selling an estimated $826M.
- Jennison Associates's ten largest holdings make up 48% of its $167B portfolio in Q4 2025.
- Jennison Associates opened 92 new positions and closed 78 in Q4 2025.
- Jennison Associates's portfolio value fell 3% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.